(trans,trans)-4-(But-3-en-1-yl)-4'-(p-tolyl)-1,1'-bi(cyclohexane)

Catalog No. :
ACCFOI216
CAS No. :
129738-42-7
Molecular Formula :
C23H34
Molecular Weight :
310.52

IUPAC Name:(1s,1'r,4R,4'R)-4-(but-3-en-1-yl)-4'-(p-tolyl)-1,1'-bi(cyclohexane)

(trans,trans)-4-(But-3-en-1-yl)-4'-(p-tolyl)-1,1'-bi(cyclohexane) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$83.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(trans,trans)-4-(But-3-en-1-yl)-4'-(p-tolyl)-1,1'-bi(cyclohexane)
IUPAC Name(1s,1'r,4R,4'R)-4-(but-3-en-1-yl)-4'-(p-tolyl)-1,1'-bi(cyclohexane)
MDL No.MFCD13188633
Molecular FormulaC23H34
Molecular Weight310.52
SMILESCC1=CC=C([C@H]2CC[C@H]([C@H]3CC[C@H](CCC=C)CC3)CC2)C=C1
InChI KeyOXPUOKDPOMJNKA-GUJRETQESA-N
SynonymMFCD13188633 | 1-[(trans,trans)-4'-(3-Buten-1-yl)[1,1'-bicyclohexyl]-4-yl]-4-methylbenzene | AKOS024462753 | FT-0658517 | DS-15448 | trans,trans-4-But-3-enyl-4'-p-tolyl-bicyclohexyl | Benzene, 1-[(trans,trans)-4'-(3-buten-1-yl)[1,1'-bicyclohexyl]-4-yl]-4-
CAS No.129738-42-7
PubChem CID18724321

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACCFOI216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQLVD372 route compound structure diagram
    ACQLVD37212012-95-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFOI216 route product structure diagram
    ACCFOI216129738-42-7 In Stock
Inquiry

2. ACCFOI216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFOI216 route product structure diagram
    ACCFOI216129738-42-7 In Stock
Inquiry

Comments (0)